Management of rheumatoid arthritis in Spain (emAR II). Clinical characteristics of the patients

Reumatol Clin. 2012 Sep-Oct;8(5):236-42. doi: 10.1016/j.reuma.2012.03.009. Epub 2012 May 19.

Abstract

Background: There is a wide variability in the diagnostic and therapeutic methods in rheumatoid arthritis (AR) in Spain, according to prior studies. The quality of care could benefit from the application of appropriate clinical practice standards; we present a study on the variability of clinical practice.

Methods: Descriptive review of clinical records (CR) of patients aged 16 or older diagnosed with RA, selected by stratified sampling of the Autonomous Communities in two stages per Hospital Center and patient. Collected analysis of sociodemographic data, evolution, follow-up, joint count, reactants, function, job history, Visual Analogue Scales (VAS) and other.

Results: We obtained valid information of 1,272 RA patients. The ESR, CRP and rheumatoid factor (RF) were regularly used parameters. The percentages of missing data in tender (TJN) and swollen (SJN) joint counts were 8.2% and 9.6% respectively; regarding the VAS we found 53.6% (patient), 59.1% (pain), and 72% in the physician VAS.

Conclusions: Despite having clinical practice guidelines on RA, there still exists a significant variability in RA management in our country.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acute-Phase Proteins / analysis
  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / blood
  • Arthritis, Rheumatoid / diagnosis
  • Arthritis, Rheumatoid / drug therapy
  • Arthritis, Rheumatoid / epidemiology
  • Arthritis, Rheumatoid / therapy*
  • Comorbidity
  • Cross-Sectional Studies
  • Disease Management
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pain Measurement
  • Peptides, Cyclic / blood
  • Practice Guidelines as Topic
  • Practice Patterns, Physicians' / statistics & numerical data*
  • Rheumatoid Factor / blood
  • Rheumatology / methods*
  • Sample Size
  • Sampling Studies
  • Severity of Illness Index
  • Socioeconomic Factors
  • Spain / epidemiology
  • Symptom Assessment

Substances

  • Acute-Phase Proteins
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antirheumatic Agents
  • Peptides, Cyclic
  • cyclic citrullinated peptide
  • Rheumatoid Factor